Back to feed

Claude Found a Hidden DNA Machine: An AI That Reads Letter by Letter Discovers a New Genome-Editing Candidate

In 21 hours and 210 million tokens, about 950 autonomous Claude agents scanning vast genomic data found a CRISPR-like repeat array around a RT system called ART in a jumbo phage genome. Its function remains unknown, but the three-part assembly adds a fresh candidate to the programmable DNA cut-copy-paste family and shows how an AI's intuitive reading of DNA can surface what pattern searches miss.

Imported to Nodesdaily: (UTC+03:00)
Watch on YouTube — H7KruLVX2Rk
Reading options

Device speech is unavailable in this browser.

Concept lens

Choose a technical term in this view to read its general definition, teaching example and use in the article.

No terms from our glossary were found in this view. The glossary does not cover every term yet.

Anthropic's new life-sciences lab, set up in spring 2026, set out to test a simple but ambitious question: can a general-purpose language model read the language of genomes without being a specialist genomics model? The first early answer is a system the team calls ART, short for array-associated RT. Reminiscent of how CRISPR first appeared as odd repeats in bacterial DNA, ART surfaced in a jumbo phage, a phage with an unusually large genome. The underlying RT gene had been seen before, but the surrounding array of non-coding repeats and an adjacent accessory protein of unknown function had never been recognized as a coherent system.

To picture why that matters, think of DNA as a master blueprint locked in a vault. When a cell needs to build a protein, it does not carry the original outside; it makes a photocopy called RNA. A RT helps make that copy. A RT (RT) runs the process backward, turning an RNA copy back into DNA and pasting it into the blueprint. That backward step is why retroviruses are called retro. ART is a small machine built around that backward writing ability, and its context suggests it may behave like a programmable editor rather than a stray enzyme.

The history of such editors is a parade of noticed oddities. Restriction enzymes that cut at short sequences in bacterial immune systems became the first DNA scissors and launched biotechnology. A heat-tolerant DNA copier from a Yellowstone bacterium enabled PCR. Later, the clustered repeats we now call CRISPR yielded the Cas9 scissors and a wave of gene-editing medicines, including glowing animal models that demonstrated precise insertion. Each leap shared a pattern: a natural programmable machine was recognized, not invented, and then repurposed. ART is presented as a candidate to join that family because it carries a feature set found together in only a handful of programmable systems that cut, copy and paste DNA.

You need retrons to understand the hint. Described in 1984, retrons are a bacterial defense against phages that works like a pin-locked grenade. The bacterium makes a toxic protein with a pin in place. When phage DNA approaches, the pin is pulled and the grenade detonates, sacrificing the infected cell to stop the virus. It is one front in a microscopic war fought every second. What Claude appears to have found looks like the phage's mirror version: once a jumbo phage colonizes a bacterium, it lays its own tripwires to keep competing viruses out, a territorial claim written in DNA.

The jumbo phage itself matters. Jumbo means its genome is unusually large, a hiker with a backpack bigger than its body, carrying a broad toolkit. In that crowded genome, Claude linked three pieces: the RT gene, a tandem array of repeats upstream, and a neighboring accessory protein with no assigned role. Taken separately each piece is unremarkable; together they form a signature that, so far, has appeared only in systems that turned out to be programmable. That is the engine analogy the video uses: you cannot find every engine by searching for the one you know, but you can recognize an engine by how its parts fit together.

How it was found is as telling as what was found. Roughly 950 agents ran for 21 hours on a DNA corpus, spending about 210 million tokens. One agent, instead of firing another script, pulled a stretch of letters into its context window and read it letter by letter, C, A, T, G, T, G, weighing whether it resembled a CRISPR-like mini-array or a retron-like repeat. Its private reasoning trace cites Jang's lab 2024 work and CRISPR pioneers, trying to name the pattern before calling it a tandem repeat array. The team notes a counterintuitive result: giving the model more tools and more pre-filtered information made it worse at describing the array, while the letter-by-letter read succeeded.

Anthropic links that to interpretability work on its large, access-controlled model Mythos 5. Internal signals in Mythos 5 responded to the repeat array in a way resembling genomics-only language models that have learned representations of repeated DNA. The report draws an analogy to a human card-game study where participants' skin conductance spiked on a bad card before they could articulate why it was bad. In Claude, the activation spike preceded the natural-language label. The implication is not mysticism but a by-product: a general model trained on broad data appears to have developed, as an emergent capacity, a representation for tandem repeats that overlaps with a specialist model's.

The find did not stay in silico. Anthropic built a wet lab so that hypotheses generated by agents can be tested end-to-end by scientists under one roof, with agents and humans collaborating at every step. The ART paper shared as a preprint by Yoon and colleagues in 2026 is the first public output of that loop, and it is not yet peer reviewed. MIT and Broad professor Feng Zhang, a pioneer of CRISPR genome editing, called it an exciting example of how AI agents can contribute to biological discovery, noting that RNA-repeat arrays tied to this RT family deserve rigorous follow-up.

The numbers invite a simple thought experiment. The scan would cost an outside user on the order of $1,000 to $5,000 at current API rates, while the CRISPR editing market it evokes is often sized in the ballpark of about $6 billion globally in 2026. In the video this is framed as an arcade machine for science: feed in compute and data, accelerate the next years of discovery. Whether that metaphor holds will depend on hit rate across the genomic ocean, but the cost anchor matters because even a one-in-hundred signal, if cheap to run and parallelizable, changes the economics of exploratory biology.

Nvidia founder Jensen Huang framed it similarly this week as a shift from discovery to engineering in the life sciences. The shared promise of CRISPR, retrons and now ART is programmability: give a short guide, tell the machine where to act, and it cuts or pastes at that address. A useful analogy is a small robot that follows coordinates. ART's programmability is not yet demonstrated; what is demonstrated is the signature that has predicted programmability elsewhere, which is why the team argues the system is worth prioritizing for biochemical characterization.

There is a broader argument about tool use here. Recent debate has pitted language models against language models plus tools, with critics discounting tool-augmented gains. This case inverts that story: the winning trace used fewer algorithmic tools and more in-context reasoning, reading DNA as text. That does not prove tools are useless; it suggests that for pattern-intuition tasks, the model's ability to hold a sequence in working memory and reason over it letter by letter can outperform pipelined search. The lab's workflow reflects that view, pairing scaffolding with moments where the model is asked to just look.

Every powerful editor is also a reminder of dual use. A phage laying defenses in a bacterium is, in ecological terms, a biological claim staked with weapons that kill competing viruses. Repurposing such a tripartite machine for human use would be engineering a weaponized architecture into a tool. Anthropic's decision to keep Mythos-class models behind verification and enterprise safeguards is part of that acknowledgement: the same capability that finds useful editors can surface architectures that demand governance before they are widely shared.

Stepping back, a single coherent signature in a single jumbo phage is unlikely to be the end. Millions of phage and bacterial genomes are sequenced and waiting, and classic control-F searches fail when the same function is built differently. What Claude did was recognize a machine by family resemblance rather than exact sequence. If wet-lab work confirms that ART can be reprogrammed to cut or copy at defined sites, the genome-editing toolbox gains a new key. If not, the lesson remains: a general model can develop a genomic intuition useful for systematizing the search for natural machines, and that systematization itself may be the more consequential engine.

Visualization: nodesdaily AI

AI commentary

"What strikes me most is the cost-speed equation: a discovery squeezed into a day and a few thousand dollars, echoing how CRISPR grew into a multi-billion-dollar industry — except this time the advance came not from brute search, but from intuitive recognition of a machine by its parts."

AI assessment

The steelman case is that ART is a candidate, not yet a tool. The paper is a preprint with no demonstrated cut-copy-paste function, and co-occurrence of three features predicts programmability but does not prove it. In the CRISPR and retron stories, similar signatures were followed by years of biochemistry before a programmable editor emerged; for ART, whether the accessory protein binds the repeats, whether the array acts as a guide, and where the RT writes will need wet-lab assays. A careful reading therefore treats the find as an exciting map pin, not a finished instrument.

Two methodological limits stand out. First, reproducibility: the observation that more tools and more pre-filtered context made the model worse suggests the discovery may hinge on a fragile reasoning path, and the hit rate across seeds is not yet reported. Second, model choice: that a general model, not a genomics specialist, supplied the intuition is striking, but it leaves open why specialist genomics models missed it and whether the Mythos 5 internal signal is causal or correlative. Without independent blind replications on the same corpus, the false-positive rate remains unknown.

On verification, the weight of evidence still rests on an Anthropic preprint and blog post, not a peer-reviewed article with open data and independent re-analysis. Quotes from Feng Zhang and Jensen Huang convey cautious optimism, not proof. The checklist for what would change minds is clear: do deletions of the repeat array abolish function, does the RT show RNA-to-DNA writing in vitro, and does the accessory protein confer targeting or stability? Once those data and datasets are public, the community can quickly test whether sister loci in related jumbo phages carry the same tripartite architecture.

The practical takeaway is about schedules. Near term, ART is a prioritized candidate for basic-research and protein-engineering labs; translation into a clinical tool, if ever, is years away and will require delivery, specificity and safety work. The economics of cheap scans are immediately actionable: runs on the order of $1,000 to $5,000, parallelized with agents, make even a low hit rate affordable for exploratory biology. That makes the arcade-machine metaphor for science compelling, but also makes governance essential, so the finding is best framed as a hypothesis to be tested and an architecture to be shared responsibly, not as a product.

Sources

7 links; 3 of them also cited by 2 other stories. Stories sharing a link do not confirm each other; a source's origin is not inferred from how often it is cited.

ai · claude · anthropic · genomics · crispr · rt · retron

Follow the topic

Before this story

A short reading order from earlier stories linked to this event by an editor.

Evidence and sources

Review permitted source passages, versions and origins.

KAYNAKLARLA OKU

Bu haberi açalım.

Hesap kontrol ediliyor…